Avid Bioservices Inc (CDMO)

[entdoc]

thanks CJ for the Brekken paper details. My take away is that PPHM associated scientists (UTSW dept.pharm, etc) have sewn this thing up as far as mechanism of action of Bavi, and the anti-PS platform potential. If I were a science advisor to a big pharma, I would give the go-ahead to negotiate stockholder assets for a piece of the action. Prostate + Bavi looks very good, as does irradiation + Bavi for almost every tumor. All this I have said before. This is a very positive report. With Bavi's safety profile to date in humans, it is easy to justify Bavi in almost any application. I want to congratulate the scientists again on this excellent and compelling addition to the Bavituximab data.